SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:52 pm Sale | 2024-09-30 | 13G | Cogent Biosciences, Inc. COGT | SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% | -5,481,034 (Position Closed) | Filing |
| 2024-02-05 4:43 pm Purchase | 2024-01-26 | 13G | Cogent Biosciences, Inc. COGT | SUVRETTA CAPITAL MANAGEMENT, LLC | 5,481,034 6.400% | 5,481,034 (New Position) | Filing |